R. Sanders Williams - 06 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Reporting relationship: Director
Issuer ticker: LH
Reported as of: 06 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Feb 2024, 12:52:23 UTC
Prior SEC filing: 12 Jun 2023
Next SEC filing: 21 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for R. Sanders Williams

Key filing fact

R. Sanders Williams filed Form 4 for LABORATORY CORP OF AMERICA HOLDINGS (LH) on 08 Feb 2024.

Key facts

This page summarizes R. Sanders Williams's Form 4 filing for LABORATORY CORP OF AMERICA HOLDINGS (LH).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Feb 2024, 12:52.

Change

Previous filing in this sequence was filed on 12 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LH transaction

Common Stock

Options Exercise

Transaction value
Shares: +947
Change %: +13%
Price
Shares after: 8,120
Date: 07 Feb 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LH transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +236
Change %: +25%
Price: $0.000000
Shares after: 1,183
Date: 06 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 236
Exercise price
Footnotes: F1, F2, F3

LH transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -947
Change %: -80%
Price: $0.000000
Shares after: 236
Date: 07 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 947
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Footnote F2

The Restricted Stock Units vest fully on February 6, 2025.

Footnote F3

This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc.

Footnote F4

The Restricted Stock Units vested fully on February 7, 2024.